1-20 of 20
Locke J. Bryan
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Musculoskeletal Pain Syndrome in a Subset of APL Patients during Induction Therapy

Michal Jakub Kubiak, Anand P. Jillella, Danielle Bradshaw, Natasha M. Savage, Ravindra Kolhe, Locke J. Bryan, Vamsi K. Kota
Journal: Blood
Blood (2022) 140 (Supplement 1): 8948–8949.
https://doi.org/10.1182/blood-2022-168090
Published: 2022
Journal Articles

Bortezomib Induced Peripheral and Severe Autonomic Neuropathy Characterized By Dizziness, Orthostatic Hypotension, and Weight Loss

Anand P. Jillella, Irina Shishkina, Gita Giddens, Courtney Corley, Kimberly Green, Rachel Ashley, Megan Johnson, Laura Walker, Sarah Jimenez, Locke J. Bryan, Ayushi Chauhan, Amany R. Keruakous, Molly James, Mohammad A.H. Mian, Danielle Bradshaw, Ravindra Kolhe, Vamsi K. Kota
Journal: Blood
Blood (2022) 140 (Supplement 1): 12547–12548.
https://doi.org/10.1182/blood-2022-166437
Published: 2022
Journal Articles

Impact of Qualified Dedicated APL Leukemia Specialist and Simplified Treatment Algorithm on Early Deaths in APL, a Monocenter Experience

Michal Jakub Kubiak, Anand P. Jillella, Danielle Bradshaw, Natasha M. Savage, Locke J. Bryan, Ravindra Kolhe, Vamsi K. Kota
Journal: Blood
Blood (2022) 140 (Supplement 1): 6108–6109.
https://doi.org/10.1182/blood-2022-168155
Published: 2022
Journal Articles

A Simplified Patient Care Strategy to Decrease Early Deaths in Acute Promyelocytic Leukemia (APL): Results of the ECOG-ACRIN EA9131 Trial

Anand P. Jillella, Sandra J. Lee, Jessica K. Altman, Selina M. Luger, Martin S. Tallman, James M. Foran, Lisa Y. Law, Locke J. Bryan, Abdallah Abou Zahr, Kebede Begna, Alexander Perl, Joseph Vadakara, Federico Sanchez, Raymond C. Bergan, Michael J. Fisch, Ruth C. Carlos, Lynne I. Wagner, Mark R. Litzow, Vamsi K. Kota
Journal: Blood
Blood (2022) 140 (Supplement 1): 1011–1013.
https://doi.org/10.1182/blood-2022-163436
Published: 2022
Journal Articles

Pembrolizumab (PEM) Added to ICE Chemotherapy Results in High Complete Metabolic Response Rates in Relapsed/Refractory Classic Hodgkin Lymphoma (cHL): A Multi-Institutional Phase II Trial

Locke J. Bryan, Carla Casulo, Pamela Allen, Scott E. Smith, Hatice Savas, Reem Karmali, Barbara Pro, Kaitlyn O'Shea, Joan Chmiel, Brett Alan Palmer, Jayesh Mehta, Leo I. Gordon, Jane N. Winter
Journal: Blood
Blood (2021) 138 (Supplement 1): 229.
https://doi.org/10.1182/blood-2021-145111
Published: 2021
Journal Articles

Rates of Neutropenic Fever in Patients with Hematologic Malignant Diseases with Central Venous Access

Sujith Abbagoni, Sarah Malik, Ashley D Fox, Mohammad A. H. Mian, Tahsin Anwar, Danielle Bradshaw, Locke J. Bryan, Anand P Jillella, Ravindra Kolhe, Natasha M. Savage, Sandeep Padala, Vamsi Kota
Journal: Blood
Blood (2021) 138 (Supplement 1): 4953.
https://doi.org/10.1182/blood-2021-154465
Published: 2021
Journal Articles

The Increased Use of Diagnostic Studies over Time in Acute Myelogenous Leukemia Patients

Chijioke Okereke, Ashley D Fox, Thuy Le, Sujith Abbagoni, Anand P Jillella, Locke J. Bryan, Tahsin Anwar, Mohammad A. H. Mian, Vamsi Kota
Journal: Blood
Blood (2021) 138 (Supplement 1): 4979.
https://doi.org/10.1182/blood-2021-154312
Published: 2021
Journal Articles

Serum Albumin As a Prognostic Factor for Overall Survival at 6-Months in Acute Myeloid Leukemia (AML)

Ashley D Fox, Chijioke Okereke, Thuy Le, Anand P Jillella, Locke J. Bryan, Tahsin Anwar, Mohammad A. H. Mian, Danielle Bradshaw, Ravindra Kolhe, Natasha M. Savage, Germame Ajebo, Sandeep Padala, Sujith Abbagoni, Vamsi Kota
Journal: Blood
Blood (2021) 138 (Supplement 1): 1226.
https://doi.org/10.1182/blood-2021-154138
Published: 2021
Journal Articles

Central Line Associated Bloodstream Infection Rate Among Hematologic Malignant Patients Who Received Antimicrobial Prophylaxis in the Inpatient Setting

Sujith Abbagoni, Thuy Le, Locke J. Bryan, Mohammad A. H. Mian, Danielle Bradshaw, Ashley D Fox, Anand P Jillella, Chijioke Okereke, Ravindra Kolhe, Natasha M. Savage, Vamsi Kota
Journal: Blood
Blood (2021) 138 (Supplement 1): 4390.
https://doi.org/10.1182/blood-2021-154524
Published: 2021
Journal Articles

Racial Variations in Mutational Profile in Newly Diagnosed Acute Myeloid Leukemia Patients

Tahsin Anwar, Mohammed Mian, Mahran Shoukier, Achuta K Guddati, Moinul Hossain, Ravindra Kolhe, MD PhD, Locke J. Bryan, Anand P Jillella, MD, Jorge E. Cortes, MD, Vamsi Kota, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 40–41.
https://doi.org/10.1182/blood-2020-143329
Published: 2020
Journal Articles

Outcomes of FLT3-Mutated Acute Myeloid Leukemia Patients: A Single Center Real-World Experience

Mahran Shoukier, Vamsi Kota, MD, Ravindra Kolhe, MD PhD, Locke J. Bryan, Anand P Jillella, MD, Jorge E. Cortes, MD
Journal: Blood
Blood (2020) 136 (Supplement 1): 22.
https://doi.org/10.1182/blood-2020-135940
Published: 2020
Journal Articles

Combination of Oral Nanatinostat (Nstat), a Novel Histone Deacetylase Inhibitor (HDACi), and the Oral Anti-Viral, Valganciclovir (VGCV), Is Active in Relapsed/Refractory (R/R) Epstein-Barr Virus (EBV)-Positive B-Cell, T-Cell, and Hodgkin Lymphoma: Interim Safety and Efficacy Results from a Phase 1b/2a Study

Pierluigi Porcu, MD, Brad M. Haverkos, MDMPH,MS, Onder Alpdogan, MD, Marcelo Capra, MD PhD, Tatyana A. Feldman, MD, Elizabeth Brem, MD, Anusha Vallurupalli, MD, Jonathan E. Brammer, MD, Ana Schriefer, Juliana Pereira, MD PhD, Anil Tulpule, MD, Stefan K. Barta, MD MRCP, MS, Locke J. Bryan, MD, Richard Trauger, Sebastian Obrzut, John Gutheil, MD, Afton Katkov, MSc, Robert McRae, Ivor Royston, MD, Douglas V. Faller, MD PhD
Journal: Blood
Blood (2019) 134 (Supplement_1): 465.
https://doi.org/10.1182/blood-2019-132004
Published: 2019
Journal Articles

Safety and Anti-Tumor Activity Study of Loncastuximab Tesirine and Ibrutinib in Diffuse Large B-Cell or Mantle Cell Lymphoma

Julien Depaus, Locke J. Bryan, MD, David Ungar, MD, Ilva Dautaj, Nina D. Wagner-Johnston, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5309.
https://doi.org/10.1182/blood-2019-126913
Published: 2019
Journal Articles

Optimize the Patient to Optimize the Therapy: Role of Prephase Cyclophosphamide in Aggressive Lymphoma

Nabin Karki, MBBS, Vamsi Kota, MBBS, Katherine Saunders, PharmD, Cara Iacobellis, PharmD, Anand Jillella, MD, Germame Ajebo, MD, Locke J. Bryan, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 5294.
https://doi.org/10.1182/blood-2019-129644
Published: 2019
Journal Articles

Safety and Toxicity Profile of Pembrolizumab (PEM) in Combination with ICE Chemotherapy Followed By Autologous Stem Cell Transplantation for Relapsed/Refractory Classical Hodgkin Lymphoma: No Impairment in Stem Cell Mobilization or Engraftment

Locke J. Bryan, MD, Scott E. Smith, MD PhD, Pamela Allen, MDMSc, Carla Casulo, Brett Alan Palmer, BS, Reem Karmali, MD, Barbara Pro, MD, Denise M Scholtens, PhD, Hatice Savas, MD, Jayesh Mehta, MD, Leo I. Gordon, MD, Jane N. Winter, MD
Journal: Blood
Blood (2019) 134 (Supplement_1): 4029.
https://doi.org/10.1182/blood-2019-123879
Published: 2019
Journal Articles

Long Term Follow-up of a Phase 2 Study Examining Intratumoral G100 Alone and in Combination with Pembrolizumab in Patients with Follicular Lymphoma

Christopher R Flowers, MD MS, Carlos Panizo, MD PhD, Iris Isufi, MD, Alex F. Herrera, MD, Craig Okada, MD PhD, Elizabeth H. Cull, MD, Bela Kis, MD, Jorge M. Chaves, MD, Nancy L. Bartlett, MD, Weiyun Ai, MD PhD, Luis de la Cruz-Merino, MD PhD, Locke J. Bryan, MD, Roch Houot, MD PhD, Kim Linton, MBChB PhD, Javier Briones, MD, Ian Chau, MD, Gottfried R. von Keudell, MD PhD, Hailing Lu, PhD, Frank J Hsu, MD, Ahmad S Halwani, MD
Journal: Blood
Blood (2018) 132 (Supplement 1): 2892.
https://doi.org/10.1182/blood-2018-99-117932
Published: 2018
Journal Articles

Intratumoral G100 Induces Systemic Immunity and Abscopal Tumor Regression in Patients with Follicular Lymphoma: Results of a Phase 1/ 2 Study Examining G100 Alone and in Combination with Pembrolizumab

Christopher Flowers, MD, Carlos Panizo, MD PhD, Iris Isufi, MD, Alex F. Herrera, MD, Craig Okada, MD PhD, Elizabeth H. Cull, MD, Bela Kis, MD, Jorge M. Chaves, MD, Nancy L. Bartlett, MD, Weiyun Ai, MD PhD, Luis de la Cruz-Merino, MD, Locke J. Bryan, MD, Roch Houot, MD PhD, Kim Linton, MBChB PhD, Javier Briones, MD, Ian Chau, MD, Gottfried R. von Keudell, MD PhD, Hailing Lu, PhD, Frank J Hsu, MD, Ahmad S. Halwani, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 2771.
https://doi.org/10.1182/blood.V130.Suppl_1.2771.2771
Published: 2017
Journal Articles

When Baking Soda Goes on Shortage

Germame Ajebo, MD, Locke J. Bryan, MD, Hoyle Whiteside, Arpita Gandhi
Journal: Blood
Blood (2017) 130 (Supplement 1): 4998.
https://doi.org/10.1182/blood.V130.Suppl_1.4998.4998
Published: 2017
Journal Articles

Microenvironment Assessment, Disease Characteristics and Prognosis In HIV-Associated (HIV-cHL) and HIV-Negative Classical Hodgkin Lymphoma: The Influence Of Epstein Barr Virus (EBV)

Paul G. Rubinstein, MD, Shylendra Sreenivasappa, MD, Marina Messinger, MD, Adam M. Petrich, MD, Jonathan Moreira, MD, Locke J. Bryan, MD, Victoria Angelova, MD, Shweta Gupta, MD, Ariela Noy, MD, Ingrid Sumpter, BS, Ethel Cesarman, MD, PhD, Amy Chadburn, M.D.
Journal: Blood
Blood (2013) 122 (21): 2996.
https://doi.org/10.1182/blood.V122.21.2996.2996
Published: 2013
Journal Articles

Is Higher Soluble P-Selectin a Risk Factor for Chronic Venous Insufficiency?

Locke J Bryan, M.D., Peter Callas, Ph.D., Michael Criqui, M.D., M.P.H., Mary Cushman, M.D., M.Sc.
Journal: Blood
Blood (2010) 116 (21): 3166.
https://doi.org/10.1182/blood.V116.21.3166.3166
Published: 2010